Pcmid - establishment of small animal models for screening mcms for the 2019 novel coronavirus (sars-COV-2)
Ended Awarded Last action
- Contract number
- 75N93020F00002
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76 Part of University Of Texas System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,445,247
Award facts
- Contract value 58% obligated
- $4,215,868.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Galveston, TX 77555, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$39,867 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $287,749 | |
| Exercise an Option | $287,749 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $631,415 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $631,415 | |
| Original award | $646,786 |
Show all 12
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to the University of Texas Medical Branch at Galveston on March 23, 2020, under the NIAID Preclinical Models of Infectious Diseases 2017–2024 IDIQ with a ceiling value of $4,215,868.11 to establish small animal models for screening medical countermeasures against SARS-CoV-2.
The NIAID IDIQ supports preclinical animal model development and medical countermeasure assessment across infectious disease research. Place of performance is Galveston, TX. The ultimate completion date was March 18, 2023. Pricing is cost-plus-no-fee.
The delivery order was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026, closing of the period of availability for those funds.
Government-invoiced labor totaled $1.805 million across FY2020–FY2023 (FY2020: $167 thousand; FY2021: $672 thousand; FY2022: $622 thousand; FY2023: $344 thousand), reflecting a declining trend. The most recent reported fiscal year (FY2023) carried 1.8 FTEs across 3,772 contractor hours at a derived rate of $91.30 per hour. The awardee self-performed all reported hours; no subcontractors were reported.
Quick answers
Who was awarded contract 75N93020F00002?
75N93020F00002 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 23, 2020.
How much is contract 75N93020F00002 worth?
The government has obligated $2,445,247 on 75N93020F00002. Its current value, with exercised options, is $4,215,868.
Is contract 75N93020F00002 an order under another contract?
Yes. 75N93020F00002 is a delivery order under HHSN272201700040I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93020F00002 competed?
The extent of competition for 75N93020F00002 was full and open competition. The government received 8 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award